| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 13 Feb 24 | KROS Keros Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 56.18 | 40,000 | 2.25 mm | 40,000 |
| 4 Jan 24 | KROS Keros Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 45.29 | 40,000 | 1.81 mm | 0 |
| 4 Jan 24 | KROS Keros Therapeutics | Common Stock | Option exercise | Acquire M | No | Yes | 16 | 40,000 | 640.00 k | 40,000 |
| 4 Jan 24 | KROS Keros Therapeutics | Employee Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 16 | 40,000 | 640.00 k | 53,622 |
| 4 Nov 23 | KROS Keros Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 45.29 | 40,000 | 1.81 mm | 0 |
| 4 Nov 23 | KROS Keros Therapeutics | Common Stock | Option exercise | Acquire M | No | Yes | 16 | 40,000 | 640.00 k | 40,000 |
